RETA

RETA contains retatrutide, a next-generation peptide currently being researched for its potential role in metabolic health, weight management, and glucose regulation. Retatrutide is being studied for its multi-receptor activity, targeting GLP-1, GIP, and glucagon receptors, which may support appetite control, energy expenditure, and insulin sensitivity.

Researchers commonly discuss RETA for its potential to assist with body composition support, reduced food cravings, and metabolic optimization. Ongoing studies continue to explore its broader applications in obesity and metabolic-related research.

Potential side effects discussed in research settings may include nausea, vomiting, decreased appetite, stomach discomfort, fatigue, or digestive upset. This product should be handled with caution and used only according to appropriate research protocols.

For research purposes only. Not intended for human consumption.